Immuno Cure is at the forefront of biotechnology, specializing in innovative immunotherapy solutions for cancers, inflammatory, and infectious diseases. The company leverages its patented PD-1-enhanced DNA vaccine platform, which utilizes a unique isoform of the PD-1 molecule to promote pro-inflammatory responses, thereby enhancing the immune system's ability to combat various diseases. This platform allows for the rapid development of highly effective DNA vaccines that are not only stable and safe but also cost-effective. The vaccines are administered intramuscularly with the aid of electroporation, which significantly improves the delivery of the DNA into muscle cells, enabling them to produce targeted antigens that stimulate robust immune responses.

In addition to its DNA vaccine technology, Immuno Cure is developing the Anti-Δ42PD1 antibody platform, which targets a specific isoform of the PD-1 molecule. This antibody has shown promise in preclinical studies for treating inflammatory-related diseases, including various cancers. The company is also advancing its pipeline with multiple vaccine candidates, such as IMC-001, a therapeutic HIV DNA vaccine, and IMC-003, which targets tumor-associated antigens for mesothelioma and other cancers. Furthermore, Immuno Cure is innovating in the delivery of its vaccines by developing needleless injection systems to enhance the efficiency and reduce the invasiveness of DNA vaccination.

China

The company is focusing on research and development of immunotherapies for cancers, inflammatory and infectious diseases based on its patented PD-1-enhanced DNA vaccine and Anti-Δ42PD1 Antibody Immuno Blocking technology platforms; with 2 vaccines in first-in-human clinical trials.

Cancer

Digestive System Diseases

Infectious Diseases

Lung Diseases

Urogenital Diseases

Immuno Cure

COVID-19

ICCOV(IMC-002A)

Biologics

Vaccines

Human immunodeficiency virus

ICVAX

ICCOV(IMC-002B)

Mesothelioma

IMC-003A

Ovarian cancer

IMC-003B

Cervical cancer

IMC-003C

Colorectal cancer

IMC-003D

Lung cancer

IMC-003E

Liver cancer

IMC-004

Antibodies

Cell Therapies

Gene Therapy

Therapeutic

Immuno Cure

Company Details